openPR Logo
Press release

Leading Companies Innovate With Over-The-Counter (OTC) Digital Therapeutics For ADHD In The US Market Trend: A Crucial Influence on the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market's Transformation in 2025

02-04-2025 06:37 AM CET | Health & Medicine

Press release from: The Business research company

Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market Share

Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market Share

"What Is the Expected Size and Growth Rate of the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market?
The attention deficit hyperactivity disorder (ADHD) therapeutics market has grown significantly in recent years. It is forecasted to rise from $13.21 billion in 2024 to $14.1 billion in 2025, with a CAGR of 6.7%. The historical expansion can be attributed to increased awareness through diagnostic and screening programs, a rising incidence of ADHD, advancements in treatment options, improvements in healthcare infrastructure, and expanded health insurance coverage.

The ADHD therapeutics market is forecasted to reach $17.25 billion by 2029, growing at a CAGR of 5.2%. Growth drivers include genetic research, mental health awareness, and telehealth expansion. Trends include innovations in treatment, digital therapeutics, precision medicine, and advancements in drug delivery systems.

What Factors Are Fueling Growth in the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market?
The increasing prevalence of attention-deficit hyperactivity disorder (ADHD) is expected to propel the growth of the ADHD therapeutics market. The rising prevalence of ADHD refers to the growing number of individuals diagnosed with this neurodevelopmental disorder over time. ADHD therapeutics address the multifaceted nature of the condition, aiming to improve symptom management, functional impairment, quality of life, and overall well-being for individuals affected by ADHD. For instance, in January 2023, according to reports published by the Guardian, a US-based news publishing company, an estimated 170,000 identified patients were prescribed ADHD medications in 2022, a 20.4% increase from 141,000 in 2021. Therefore, the increasing prevalence of ADHD is driving the growth of the ADHD therapeutics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14042&type=smp

Which Leading Companies Are Shaping the Growth of the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market?
Major companies operating in the attention deficit hyperactivity disorder (ADHD) therapeutics market are Pfizer Inc., Johnson And Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical's, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., UCB S.A., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Purdue Pharma L.P., Arbor Pharmaceuticals LLC, Tris Pharma Inc., NEOS Therapeutic Inc., Concert Pharmaceuticals Inc., Vayarin AG, Rhodes Pharmaceuticals L.P., KemPharm Inc., Impax Laboratories Inc., Aevi Genomic Medicine, Adlon Therapeutics L.P., Ironshore Pharmaceuticals Inc., Highland Therapeutics Inc.

What Are the Major Trends Shaping the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market?
In the ADHD therapeutics market, companies are focusing on digital solutions like Endeavor's over-the-counter (OTC) digital therapeutics for ADHD to meet the rising demand for digital healthcare options. Digital therapeutics involve software-driven interventions that aim to prevent, manage, or treat medical conditions. For example, in June 2023, Akili, a US-based digital health company, introduced an OTC version of its video game-based digital therapeutic for adults with ADHD. The OTC version, EndeavorOTC, helps improve attention, time management, and organizational skills, offering an alternative to medication. This follows the success of Akili's FDA-approved EndeavorRx treatment for children with ADHD.

What Are the Key Segments of the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market?
The attention deficit hyperactivity disorder (ADHD) therapeutics market covered in this report is segmented -

1) By Drug Type: Stimulants, Non-Stimulants
2) By Psychotherapy: Behavior Therapy, Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Family Therapy
3) By Age Group: Pediatric And Adolescent, Adult
4) By Distribution Channel: Hospital Pharmacies, Specialty Clinics, Retail Pharmacies, E-Commerce

Subsegments:
1) By Stimulants: Amphetamine-Based Stimulants, Methylphenidate-Based Stimulants
2) By Non-Stimulants: Atomoxetine, Guanfacine, Clonidine

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-adhd-therapeutics-global-market-report

Which Region Dominates the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market?
North America was the largest region in the attention deficit hyperactivity disorder (ADHD) therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Attention Deficit Hyperactivity Disorder ADHD Therapeutics Global Market Report?

- Market Size Analysis: Analyze the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14042

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leading Companies Innovate With Over-The-Counter (OTC) Digital Therapeutics For ADHD In The US Market Trend: A Crucial Influence on the Attention Deficit Hyperactivity Disorder ADHD Therapeutics Market's Transformation in 2025 here

News-ID: 3848084 • Views:

More Releases from The Business research company

Pesticide And Other Agricultural Chemicals Industry Set to Achieve $156.05 Billion Milestone by 2029 | Steady 8.4% CAGR
Pesticide And Other Agricultural Chemicals Industry Set to Achieve $156.05 Billi …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Pesticide And Other Agricultural Chemicals Market Size 2025? In recent years, the market size for pesticides and other agricultural chemicals has witnessed significant growth. From a value of $104.46 billion in 2024, it's projected to swell to $113.13 billion in 2025, reflecting a compound
Organophosphates Pesticides Industry Expected to Reach $10.67 Billion by 2029 at 6.1% CAGR
Organophosphates Pesticides Industry Expected to Reach $10.67 Billion by 2029 at …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. Organophosphates Pesticides Market Value Projection: How Much Will the Market Size by 2025? The market size of organophosphates pesticides has experienced consistent growth in the prior years. The market is projected to expand from $8.05 billion in 2024 to $8.41 billion in 2025, with a compound annual growth rate (CAGR) of
Nitrobenzene Industry Growth Outlook: 7.5% CAGR and $15.35 Billion by 2029
Nitrobenzene Industry Growth Outlook: 7.5% CAGR and $15.35 Billion by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Nitrobenzene Market Size 2025? In the past few years, the size of the nitrobenzene market has witnessed significant growth. It is projected to increase from $10.96 billion in 2024 to $11.51 billion in 2025, with a compound annual growth rate (CAGR) of 5.1%. The
Nail Polish Market Analysis: $24.61 Billion by 2029 With a CAGR of 11.5%
Nail Polish Market Analysis: $24.61 Billion by 2029 With a CAGR of 11.5%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. Nail Polish Market Value Projection: How Much Will the Market Size by 2025? The industry of nail polish has witnessed significant expansion in the past few years. Projected to surge from $14.39 billion in 2024 to $15.93 billion in 2025, it is expected to observe a compound annual growth rate (CAGR)

All 5 Releases


More Releases for ADHD

My ADHD Life Journal by Meryl Bengtsson Offers a Fresh, Reflective Tool for ADHD …
Image: https://www.globalnewslines.com/uploads/2025/05/1748624322.jpg In a world that often pushes individuals with ADHD to "try harder" or "focus more," author and ADHD life coach Meryl Bengtsson invites you to try something radically different. With her book and courses, she encourages you to listen to yourself. Her new book, My ADHD Life Journal: Building Self-Awareness [https://www.amazon.co.uk/My-ADHD-Life-Journal-Self-Awareness/dp/1967679673/], is a deeply personal and practical resource designed to guide individuals on a journey of gentle reflection and
Rising Prevalence Of ADHD Spurs Growth In The Attention-Deficit Hyperactivity Di …
The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market? The market size for therapeutics related to attention deficit hyperactivity disorder (ADHD) has seen significant growth in
ADHD Awareness Month: Dance Academy Founder Shares How Dance Helps Manage ADHD
This ADHD Awareness Month, Nix Academy - an up and coming dance and performing arts school - is highlighting the powerful impact of dance on managing ADHD symptoms. Founded by Nicky Rowe, who herself has ADHD, the academy has become a beacon of inclusivity, with around 40% of its students identifying as neurodiverse. "Dance has been my lifeline in managing ADHD," says Nicky Rowe, Founder and Principal Teacher at Nix Academy.
Global ADHD Drugs Market Research Report 2017
Qyresearchreports include new market research report "Global ADHD Drugs Market Research Report 2017" to its huge collection of research reports. The research report offers a comprehensive analysis of the global ADHD Drugs market, emphasizing on the key factors impacting the growth of the market. The factors affecting the growth of the market have been studied thoroughly and valuation of the market has been provided in the report. This report provides accurate
ADHD Answers from an ADHD Teen Brings Help to Parents, ADHD Boys
Sept. 4, 2006--Parents of boys with Attention Deficit Disorder (ADHD) have a new place to find answers to questions, problem-solving suggestions, and general help and support, both for their sons and for themselves. But the help comes from a source some will find surprising. \"Talk Back with Jack\" offers a forum for 11-year-old Jack Dixon to offer help and advice to ADHD boys and their parents as part of That\'s
ADHD Myths — What If There Really Isn’t Anything Wrong with ADHD Children?
February 6, 2006 (Washington, D.C.) - An ADHD diagnosis can often signal a lifetime of struggles for children. But consider the case of Robbie Raffino. Robbie used to rise every day like most eight-year-olds. He'd wipe the sleepiness from his eyes, throw on shorts and shirt that don't match and eat cereal while watching cartoons. But the innocence ended there. He'd swallow his Ritalin, hop on the school bus and enter